ALKEM — Alkem Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Alkem Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	83,444	88,650	106,342	115,993	126,676
Cost of Revenue
Gross Profit	49,248	52,759	63,704	66,688	77,300
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	70,574	71,955	88,627	103,201	107,214
Operating Profit	12,870	16,695	17,715	12,792	19,462
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	12,598	18,421	18,443	13,048	20,231
Provision for Income Taxes
Net Income After Taxes	11,493	16,178	16,803	10,068	18,115
Minority Interest
Net Income Before Extraordinary Items
Net Income	11,271	15,850	16,456	9,842	17,958
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	11,271	15,850	16,456	9,842	17,958
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	94.4	130	138	89.9	150
Dividends per Share
Special Dividends per Share